1. Home
  2. PBYI vs ISTR Comparison

PBYI vs ISTR Comparison

Compare PBYI & ISTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBYI
  • ISTR
  • Stock Information
  • Founded
  • PBYI 2010
  • ISTR 2006
  • Country
  • PBYI United States
  • ISTR United States
  • Employees
  • PBYI N/A
  • ISTR N/A
  • Industry
  • PBYI Biotechnology: Pharmaceutical Preparations
  • ISTR Major Banks
  • Sector
  • PBYI Health Care
  • ISTR Finance
  • Exchange
  • PBYI Nasdaq
  • ISTR Nasdaq
  • Market Cap
  • PBYI 171.7M
  • ISTR 222.8M
  • IPO Year
  • PBYI N/A
  • ISTR 2014
  • Fundamental
  • Price
  • PBYI $4.52
  • ISTR $22.62
  • Analyst Decision
  • PBYI Strong Buy
  • ISTR Buy
  • Analyst Count
  • PBYI 1
  • ISTR 1
  • Target Price
  • PBYI $7.00
  • ISTR $27.00
  • AVG Volume (30 Days)
  • PBYI 592.1K
  • ISTR 36.4K
  • Earning Date
  • PBYI 11-06-2025
  • ISTR 10-20-2025
  • Dividend Yield
  • PBYI N/A
  • ISTR 1.93%
  • EPS Growth
  • PBYI 434.29
  • ISTR 46.46
  • EPS
  • PBYI 0.97
  • ISTR 2.24
  • Revenue
  • PBYI $238,062,000.00
  • ISTR $90,651,000.00
  • Revenue This Year
  • PBYI N/A
  • ISTR $10.96
  • Revenue Next Year
  • PBYI N/A
  • ISTR $61.82
  • P/E Ratio
  • PBYI $4.65
  • ISTR $10.19
  • Revenue Growth
  • PBYI 8.63
  • ISTR 12.41
  • 52 Week Low
  • PBYI $2.32
  • ISTR $15.39
  • 52 Week High
  • PBYI $6.07
  • ISTR $24.81
  • Technical
  • Relative Strength Index (RSI)
  • PBYI 51.02
  • ISTR 51.69
  • Support Level
  • PBYI N/A
  • ISTR N/A
  • Resistance Level
  • PBYI $5.22
  • ISTR $23.16
  • Average True Range (ATR)
  • PBYI 0.24
  • ISTR 0.32
  • MACD
  • PBYI -0.28
  • ISTR -0.95
  • Stochastic Oscillator
  • PBYI 83.09
  • ISTR 95.44

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

About ISTR Investar Holding Corporation

Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.

Share on Social Networks: